Reducing waste from incomplete or unusable reports of biomedical research

[1]  G. Collins,et al.  Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting , 2011, BMC medicine.

[2]  D. Altman,et al.  Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial , 2011, BMJ : British Medical Journal.

[3]  David Morgan,et al.  Statisticians in the Pharmaceutical Industry (PSI) , 2005 .

[4]  D. Moher,et al.  The nuts and bolts of PROSPERO: an international prospective register of systematic reviews , 2012, Systematic Reviews.

[5]  D. Rennie,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.

[6]  D. Altman,et al.  Inadequate post-publication review of medical research , 2010, BMJ : British Medical Journal.

[7]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[8]  Jennifer P Morton,et al.  MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma , 2011, Clinical Cancer Research.

[9]  C. Gluud,et al.  Citation bias of hepato-biliary randomized clinical trials. , 2002, Journal of clinical epidemiology.

[10]  Johannes B Reitsma,et al.  Overinterpretation and misreporting of diagnostic accuracy studies: evidence of "spin". , 2013, Radiology.

[11]  Joel D. Martin,et al.  ExaCT: automatic extraction of clinical trial characteristics from journal publications , 2010, BMC Medical Informatics Decis. Mak..

[12]  E. Steyerberg,et al.  Reporting and Methods in Clinical Prediction Research: A Systematic Review , 2012, PLoS medicine.

[13]  Sally Hopewell,et al.  Reporting of adverse events in systematic reviews can be improved: survey results. , 2008, Journal of clinical epidemiology.

[14]  Sally Hopewell,et al.  Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting , 2010, The Lancet.

[15]  M. Clarke,et al.  Many reports of randomised trials still don’t begin or end with a systematic review of the relevant evidence , 2013 .

[16]  Carl Heneghan,et al.  What is missing from descriptions of treatment in trials and reviews? , 2008, BMJ : British Medical Journal.

[17]  T. George,et al.  Adequacy of published oncology randomized controlled trials to provide therapeutic details needed for clinical application. , 2010, Journal of the National Cancer Institute.

[18]  D. Altman,et al.  Unjustified Restrictions on Letters to the Editor , 2005, PLoS medicine.

[19]  J. Ioannidis,et al.  Persistence of contradicted claims in the literature. , 2007, JAMA.

[20]  B. Djulbegovic,et al.  Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols. , 2012, Journal of clinical epidemiology.

[21]  S. Todd,et al.  Making available information from studies sponsored by the pharmaceutical industry: some current practices , 2011, Pharmaceutical statistics.

[22]  I. Cuthill,et al.  Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals , 2009, PloS one.

[23]  R. Dellavalle,et al.  Inaccessible novel questionnaires in published medical research: hidden methods, hidden costs. , 2006, American journal of epidemiology.

[24]  David Moher,et al.  Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa , 2012, Systematic Reviews.

[25]  Carl van Walraven,et al.  Time-dependent bias was common in survival analyses published in leading clinical journals. , 2004, Journal of clinical epidemiology.

[26]  S. Andreassen,et al.  Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review. , 2009, The Journal of antimicrobial chemotherapy.

[27]  Claire Glenton,et al.  Summaries of findings, descriptions of interventions, and information about adverse effects would make reviews more informative. , 2006, Journal of clinical epidemiology.

[28]  I. Tannock,et al.  Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  P. Glasziou,et al.  Avoidable waste in the production and reporting of research evidence , 2009, The Lancet.

[30]  Rebecca J Williams,et al.  QUALITY OF TRIALS Impact of a Systematic Review on Subsequent Clinical Research : The Case of the Prevention of Propofol Injection Pain , 2013 .

[31]  Douglas G Altman,et al.  Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. , 2010, JAMA.

[32]  I. Boutron,et al.  Inadequate description of educational interventions in ongoing randomized controlled trials , 2012, Trials.

[33]  Joshua Carp,et al.  The secret lives of experiments: Methods reporting in the fMRI literature , 2012, NeuroImage.

[34]  E. Wager.  Publishing Clinical Trial Results: The Future Beckons , 2006, PLoS clinical trials.

[35]  C A Gatsonis,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. , 2003, Clinical radiology.

[36]  T Jefferson.  Structuring the discussion of scientific papers , 1999, BMJ.

[37]  Gary S Collins,et al.  Reporting of participant flow diagrams in published reports of randomized trials , 2011, Trials.

[38]  Brian A. Nosek,et al.  Scientific Utopia , 2012, Perspectives on psychological science : a journal of the Association for Psychological Science.

[39]  D. Moher,et al.  Guidance for Developers of Health Research Reporting Guidelines , 2010, PLoS medicine.

[40]  David Moher,et al.  Why prospective registration of systematic reviews makes sense , 2012, Systematic Reviews.

[41]  A. Hrõbjartsson,et al.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.

[42]  A. V. Pollock.  How to Report Statistics in Medicine , 2001 .

[43]  Elizabeth Wager,et al.  Technical editing of research reports in biomedical journals. , 2008, The Cochrane database of systematic reviews.

[44]  D. Moher.  Guidelines for reporting health care research: advancing the clarity and transparency of scientific reporting , 2009, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[45]  M Docherty,et al.  The case for structuring the discussion of scientific papers , 1999, BMJ.

[46]  David L Schriger,et al.  Graphical literacy: the quality of graphs in a large-circulation journal. , 2002, Annals of emergency medicine.

[47]  Douglas G Altman,et al.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration , 2012, BMC Medicine.

[48]  G. Rücker,et al.  Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles , 2011, BMJ : British Medical Journal.

[49]  W. Sauerbrei,et al.  Reporting recommendations for tumor marker prognostic studies (REMARK). , 2005, Journal of the National Cancer Institute.

[50]  M Sievert,et al.  Effects of article retraction on citation and practice in medicine. , 1999, Bulletin of the Medical Library Association.

[51]  P. Bossuyt,et al.  The quality of diagnostic accuracy studies since the STARD statement , 2006, Neurology.

[52]  T. Lewins,et al.  Fit for purpose , 2000 .

[53]  C. Gross,et al.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review. , 2003, JAMA.

[54]  S. Goodman,et al.  A Systematic Examination of the Citation of Prior Research in Reports of Randomized, Controlled Trials , 2011, Annals of Internal Medicine.

[55]  David Moher,et al.  [CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration]. , 2008, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[56]  D. Cook,et al.  The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals. , 2009, Journal of clinical epidemiology.

[57]  N. Dendukuri,et al.  Quality and Reporting of Diagnostic Accuracy Studies in TB, HIV and Malaria: Evaluation Using QUADAS and STARD Standards , 2009, PloS one.

[58]  S. Todd,et al.  Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry‐sponsored clinical trials , 2011, Pharmaceutical statistics.

[59]  R. Forgan.  VENEREAL DISEASE IN THE NAVY , 1925 .

[60]  Loren H. Rieseberg,et al.  How reliable is science information on the web? , 1999, Nature.

[61]  David Moher,et al.  Reporting Guidelines for Survey Research: An Analysis of Published Guidance and Reporting Practices , 2011, PLoS medicine.

[62]  Consort Grou.  Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement , 2006 .

[63]  D. Sackett,et al.  Methods of Blinding in Reports of Randomized Controlled Trials Assessing Pharmacologic Treatments: A Systematic Review , 2006, PLoS medicine.

[64]  J. Ioannidis,et al.  Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias , 2008, PloS one.

[65]  R. Warren.  Reasons for writing. , 1973, Archives of surgery.

[66]  Lisa Bero,et al.  Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation , 2008, PLoS medicine.

[67]  Sally Hopewell,et al.  Effect of editors’ implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis , 2012, BMJ : British Medical Journal.

[68]  D. Altman,et al.  ACP Journal Club. Editorial: Writing a research article that is "fit for purpose": EQUATOR Network and reporting guidelines. , 2009, Annals of internal medicine.

[69]  T. Forbes.  Author disclosure of conflict of interest in vascular surgery journals. , 2011, Journal of vascular surgery.

[70]  Steven Woloshin,et al.  Press Releases by Academic Medical Centers: Not So Academic? , 2009, Annals of Internal Medicine.

[71]  Peter C Gøtzsche,et al.  [Better reporting of harms in randomized trials: an extension of the CONSORT statement]. , 2005, Ugeskrift for laeger.

[72]  Veronica Yank,et al.  Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study , 2007, BMJ : British Medical Journal.

[73]  K. Dickersin.  Reference bias in reports of drug trials. , 1987, British medical journal.

[74]  Harlan M Krumholz,et al.  Increasing value and reducing waste: addressing inaccessible research , 2014, The Lancet.

[75]  I. Cuthill,et al.  Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research † , 2012, Osteoarthritis and cartilage.

[76]  D. Fanelli.  How Many Scientists Fabricate and Falsify Research? A Systematic Review and Meta-Analysis of Survey Data , 2009, PloS one.

[77]  Claire Glenton,et al.  Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study , 2009, BMJ : British Medical Journal.

[78]  Stephanie Clark,et al.  Putting research into context—revisited , 2010, The Lancet.

[79]  M. Tramèr,et al.  Prevention of Pain on Injection with Propofol: A Quantitative Systematic Review , 2000, Anesthesia and analgesia.

[80]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[81]  Assessing the quality of newspaper medical advice columns for elderly readers. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[82]  Nicholas C. Ide,et al.  Trial Registration at ClinicalTrials.gov between May and October 2005. , 2005, The New England journal of medicine.

[83]  J. Ioannidis,et al.  Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. , 2011, Circulation. Cardiovascular genetics.

[84]  C. Abraham,et al.  Effective techniques in healthy eating and physical activity interventions: a meta-regression. , 2009, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[85]  J. Ioannidis,et al.  STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement , 2009, PLoS medicine.

[86]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, BMC medicine.

[87]  A. Hoes,et al.  Poor quality of reporting confounding bias in observational intervention studies: a systematic review. , 2008, Annals of epidemiology.